Home › Trial NCT05761977
Durvalumab in Combination With Standard Chemotherapy of Patients With Extensive Stage Small Cell Lung Cancer
- Trial IDNCT05761977
- StatusActive Not Recruiting
- PhaseN/A
- Study typeObservational
- SponsorHellenic Cooperative Oncology Group
- Enrollment50
- Start date2021-03-31
- ConditionsSmall-cell Lung Cancer · Extensive-stage Small-cell Lung Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.